Registry for patients receiving proton radiation therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Johns Hopkins Proton Therapy center is creating a registry to collect detailed information on patients treated with proton radiation therapy, including 3D radiation dosimetry, baseline clinical data, and outcomes related to disease, toxicity, and quality of life. This observational approach aims to include all patients treated at the center to facilitate future comparisons of treatment outcomes. By capturing comprehensive data, the registry seeks to enhance understanding of which patient populations benefit most from proton therapy, despite its higher costs compared to traditional photon therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients treated at the proton center.

Exclusion Criteria:

* Any other than what is supplied in the inclusion criteria

Where it's running

• Sibley Memorial Hospital
  Washington D.C., District of Columbia, United States Recruiting
• Suburban Hospital
  Washington D.C., District of Columbia, United States Recruiting
• Bayview Hospital
  Baltimore, Maryland, United States Recruiting
• Johns Hopkins Hospital
  Baltimore, Maryland, United States Recruiting

Study contacts

• Principal investigator: Curtiland Deville, MD — Johns Hopkins University
• Study coordinator: Akila Viswanathan, MD
• Email: anv@jhmi.edu
• Phone: 410-502-1421

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Photo-based exploration of hope in young people receiving phase 1/2 cancer therapy

  This project will try to understand how young people (ages 12–25) and their caregivers experience and adapt their hope while they are enrolled in phase 1 or 2 cancer therapy using photos and interviews.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07444216

• How probiotics affect survival, treatment response, and gut microbiota during cancer therapy

  This test will see if taking a probiotic supplement during cancer treatment helps adults with cancer live longer, respond better to therapy, or have healthier gut bacteria.

  Recruiting Chang Gung Memorial Hospital · New Taipei City · NCT06998823

• Maintenance therapy for colorectal cancer patients after liver surgery

  This study is testing if adding maintenance therapy to standard chemotherapy can help colorectal cancer patients with liver metastases live longer without their cancer getting worse after surgery.

  Recruiting Phase 3 Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT05797077

• Walking exercise to reduce fatigue in older breast cancer survivors

  This study is testing whether two types of walking exercises can help older women who have survived breast cancer feel less tired.

  Recruiting University of Florida · Gainesville, Florida · NCT05684367

• Using Sacubitril/Valsartan to prevent heart damage in breast cancer treatment

  This study is testing if the medication Sacubitril/Valsartan can help protect the hearts of women undergoing treatment for breast cancer from damage.

  Recruiting at 3 sites Phase 4 Silesian Centre for Heart Diseases · Opole, Opole Voivodeship and 3 other locations · NCT05465031

• Registry for patients receiving proton therapy

  This study is creating a registry to gather information from patients receiving proton therapy for cancer to see how well the treatment works and who benefits the most.

  Recruiting at 2 sites Clinica Universidad de Navarra, Universidad de Navarra · Pamplona, Navarre and 1 other locations · NCT05151952

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.